A new study, led by experts at the University of Nottingham, has found that medicines used to treat gout can also reduce the risk of heart attack and stroke in people with gout. The new research, ...

Gout patients with kidney problems got better uric acid control from an extended-release version of febuxostat than from the ...

A research team at the University of Virginia Hospital System found that a regularly-used medication for gout, called colchicine, helped improve the survival rates of hospitalized heart failure ...

In recent years, scientists have increasingly turned their attention to older, affordable drugs to explore whether they offer benefits beyond their original purpose. Colchicine, a cheap and widely ...

The use of SGLT2 inhibitors (SGLT2i) was associated with fewer gout flares and reduced use of gout medication among adults with both gout and type 2 diabetes (T2D), according to results of a new study ...

TOKYO, Oct 8, 2024 - (JCN Newswire) - - Eisai Co., Ltd. announced today that it has received approval for "URECE Tablets" (dotinurad) in Thailand as a treatment for gout and hyperuricemia. This ...

Just one in three patients with gout in the U.K. received preventative medication within a year of diagnosis, new research has found. The study is published today in The Lancet Regional Health—Europe ...

Diet can also be a key factor in the development of gout. Avoiding foods high in purines, such as red meat, can help lower risk. Medications taken to treat gout can help people with that condition ...

A gout medication can reduce the risk of a heart attack or stroke, according to new research. The pioneering study found that drugs used to treat the common but painful form of arthritis can also cut ...

Allopurinol, a frequently used gout medication, does not appear to drive up the risk for dying among gout patients who also struggle with chronic kidney disease, new research shows. The finding is ...

Just 1 in 3 people with gout was prescribed recommended preventive medication within a year of diagnosis, according to a new study from King’s College London (KCL). Even fewer – just 1 in 6 patients - ...